he says: strains of bacteria produce the very same enzymes, i.e. beta-galactosidase and sialidase used to make chemical GcMAF (p 14). plus colostrum for protein. I found these mentions in pubmed, but maybe other bacteria also make it.
If yoghurt is good for immune system anyway. I think we should try to reproduce it. Or someone analyze their yogurt.
A selected probiotic strain of Lactobacillus fermentum CM33 isolated from breast-fed infants as a potential source of ?-galactosidase for prebiotic oligosaccharide synthesis.
Sriphannam W, Lumyong S, Niumsap P, Ashida H, Yamamoto K, Khanongnuch C.
J Microbiol. 2012 Feb;50(1):119-26. Epub 2012 Feb 27.
PMID: 22367946 [PubMed - in process]
Related citations
Biotechnol Lett. 2012 Feb 15. [Epub ahead of print]
Analysis of ?-galactosidase production and their genes of two strains of Lactobacillus bulgaricus.
Zhang W, Wang C, Huang CY, Yu Q, Liu HC, Zhang CW, Pei XF, Xu X, Wang GQ.
Source
Department of Nutrition and Food Hygiene, West China School of Public Health, Sichuan University, #16, Section3, Renmin Nan Road, Chengdu, 610041, Sichuan, China,
wendyzhang1982@163.com.
Abstract
A bacterial ?-galactosidase delivery system is a potential therapy for lactose intolerance. Currently, two Lactobacillus bulgaricus strains with different biological characteristics are under consideration as potential sources. However, differences in these ?-galactosidase genes and their resulting production levels are poorly characterized. The ?-galactosidase ORF of L. bulgaricus yogurt isolate had high variability and was terminated at site 1924 due to a stop codon. However, the full 114kDa ?-galactosidase band was still resolved by SDS-PAGE, which may indicate that the interrupted ORF was translated into more than one peptide, and they together were folded into the complete enzyme protein that showed much higher ?-galactosidase activity (6.2U/mg protein) than the enzyme generated from L. bulgaricus reference strain (2.5U/mg protein).
A selected probiotic strain of Lactobacillus fermentum CM33 isolated from breast-fed infants as a potential source of ?-galactosidase for prebiotic oligosaccharide synthesis.
Sriphannam W, Lumyong S, Niumsap P, Ashida H, Yamamoto K, Khanongnuch C.
J Microbiol. 2012 Feb;50(1):119-26. Epub 2012 Feb 27.
PMID: 22367946 [PubMed - in process]
Related citations
Biotechnol Lett. 2012 Feb 15. [Epub ahead of print]
Analysis of ?-galactosidase production and their genes of two strains of Lactobacillus bulgaricus.
Zhang W, Wang C, Huang CY, Yu Q, Liu HC, Zhang CW, Pei XF, Xu X, Wang GQ.
Source
Department of Nutrition and Food Hygiene, West China School of Public Health, Sichuan University, #16, Section3, Renmin Nan Road, Chengdu, 610041, Sichuan, China,
wendyzhang1982@163.com.
Abstract
A bacterial ?-galactosidase delivery system is a potential therapy for lactose intolerance. Currently, two Lactobacillus bulgaricus strains with different biological characteristics are under consideration as potential sources. However, differences in these ?-galactosidase genes and their resulting production levels are poorly characterized. The ?-galactosidase ORF of L. bulgaricus yogurt isolate had high variability and was terminated at site 1924 due to a stop codon. However, the full 114kDa ?-galactosidase band was still resolved by SDS-PAGE, which may indicate that the interrupted ORF was translated into more than one peptide, and they together were folded into the complete enzyme protein that showed much higher ?-galactosidase activity (6.2U/mg protein) than the enzyme generated from L. bulgaricus reference strain (2.5U/mg protein).